Article de revue

Assessing the potency of oral polio vaccine kept outside of the coldchain

This study is the first systematic documentation of the potency of monovalent oral polio vaccine type 3 (mOPV3) kept at ambient temperatures during a polio immunization campaign in Chad. During the study test vials were exposed to temperatures of up to 47.1 °C, and kept outside of the 2–8 °C range for a maximum of 86.9 hours. Post-campaign laboratory testing confirmed that the test vials were still potent, and in conformity with the defined release specifications. Further, the Vaccine Vial Monitors performed as expected, giving an early warning indication of when cumulative exposure to heat reached levels that may have negatively affected the vaccine\'s potency. This study provides proof-of-concept evidence that certain types of OPV remain potent and thus can be kept, for limited periods of time, as well as administered at ambient temperatures.

Langues

  • Anglais

Année de publication

2011

Journal

Vaccine

Volume

34

Type

Article de revue

Catégories

  • Chaîne d'approvisionnement

Maladies

  • Polio

Pays

  • Tchad

Mots-clés

  • OPV
  • VVM
  • Wastage

Régions de l'OMS

  • Région africaine

Références sur le sujet

VVM-CTC

TitreAuteurAnnéeTypeLangue
Assessing the potency of oral polio vaccine kept outside of the coldchainSimona Zipursky et al.2011Journal articleAnglais
Benefits of using vaccines out of the cold chain: Delivering Meningitis A vaccine in a controlled temperature chain during the mass immunization campaign in BeninSimona Zipursky, Mamoudou Harouna Djingarey, Jean-Claude Lodjo, Laifoya Olodo, Sylvestre Tiendrebeogo, Olivier Ronveaux2014Journal articleAnglais
Extending supply chains and improving immunization coverage and equity through controlled temperature chain use of vaccinesRaja Rao, Debra Kristensen, Anna-Lea Kahn2017Journal articleAnglais
Vaccines beyond the cold chain - Simona ZipurskyEPELA, World Health Organization (WHO)2013GuidanceAnglais